Literature DB >> 8982505

Effects of competitive and noncompetitive antagonists of the N-methyl-D-aspartate receptor on the analgesic action of delta 1- and delta 2-opioid receptor agonists in mice.

H N Bharagava1, G M Zhao.   

Abstract

1. The effects of MK-801, a noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) receptor and LY 235959, a competitive antagonists of the NMDA receptor on the analgesic actions of [D-Pen2,D-Pen5]enkephalin (DPDPE) and [D-Ala2, Glu4] deltorphin II (deltorphin II), the putative delta 1- and delta 2-opioid receptor agonists, respectively, were determined in the male Swiss-Webster mice. 2. Intracerebroventricular administration of DPDPE or deltorphin II produced analgesia. MK-801 administered intraperitoneally 10 min before the injection of DPDPE or deltorphin II, dose-dependently antagonized the analgesic actions of both drugs. 3. LY 235959 also dose-dependently antagonized the analgesic actions of DPDPE and deltorphin II. 4. The effects of MK-801 and LY 235959 on the binding of [3H]-DPDPE to mouse brain membranes were also determined. Neither of the NMDA receptor antagonists had any effect on the binding of [3H]-DPDPE. 5. It is concluded that competitive and noncompetitive antagonists of the NMDA receptor antagonize the analgesic action of delta 1- and delta 2-opioid receptor agonists and that such effects are not mediated via a direct interaction with brain delta-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982505      PMCID: PMC1915802          DOI: 10.1111/j.1476-5381.1996.tb16076.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception.

Authors:  B Kest; P Marek; J C Liebeskind
Journal:  Brain Res       Date:  1992-08-28       Impact factor: 3.252

2.  Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801.

Authors:  K A Trujillo; H Akil
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

3.  Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia.

Authors:  S M Lipa; M Kavaliers
Journal:  Brain Res Bull       Date:  1990-04       Impact factor: 4.077

4.  Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.

Authors:  A Mattia; T Vanderah; H I Mosberg; F Porreca
Journal:  J Pharmacol Exp Ther       Date:  1991-08       Impact factor: 4.030

5.  delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites.

Authors:  M Sofuoglu; P S Portoghese; A E Takemori
Journal:  Eur J Pharmacol       Date:  1992-06-05       Impact factor: 4.432

6.  Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.

Authors:  M Sofuoglu; P S Portoghese; A E Takemori
Journal:  J Pharmacol Exp Ther       Date:  1991-05       Impact factor: 4.030

7.  Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat.

Authors:  P Marek; S Ben-Eliyahu; M Gold; J C Liebeskind
Journal:  Brain Res       Date:  1991-04-26       Impact factor: 3.252

8.  The NMDA receptor: central role in pain inhibition in rat periaqueductal gray.

Authors:  Y F Jacquet
Journal:  Eur J Pharmacol       Date:  1988-09-23       Impact factor: 4.432

9.  Comparison of primary afferent and glutamate excitation of neurons in the mammalian spinal dorsal horn.

Authors:  S P Schneider; E R Perl
Journal:  J Neurosci       Date:  1988-06       Impact factor: 6.167

10.  The role of glutamate in opiate descending inhibition of nociceptive spinal reflexes.

Authors:  H van Praag; H Frenk
Journal:  Brain Res       Date:  1990-07-30       Impact factor: 3.252

View more
  1 in total

Review 1.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.